Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
398 *
Tue, 8/1/2017,
2:00 PM -
3:50 PM
CC-346
Different Approaches to the Increase of a Sample Size When the Unblinded Interim Estimate of the Treatment Effect Looks Promising — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Mikhail Peter Salganik, Pfizer Worldwide Research & Development, Pfizer, Inc
Chair(s): Sandeep Menon, Pfizer, Inc
2:05 PM
An Evaluation of Increasing Sample Size Based on Conditional Power
—
Michael Gaffney, Pfizer Inc.
2:25 PM
Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-Assessment
—
Sam Hsiao, Cytel, Inc ; Lingyun Liu, Cytel, Inc ; Cyrus Mehta, Cytel Inc
2:45 PM
Extensions of Adaptive Sample Size Re-Estimation Methods to the Negative Binomial Setting
—
Mikhail Peter Salganik, Pfizer Worldwide Research & Development, Pfizer, Inc ; Sandeep Menon, Pfizer, Inc ; Abigail Sloan, Harvard T.H. Chan School of Public Health
3:05 PM
Adapting the 5-Zone Adaptive Design
—
Yi Liu, Takeda ; Mingxiu Hu, Takeda Pharmaceutical
3:25 PM
Implementation of Promising Zone Methodology in a Ph 3 Trial in AML (VALOR)
—
Jennifer Smith, Sunesis
3:45 PM
Floor Discussion